GO:0004419 hydroxymethylglutaryl-CoA lyase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004419 defines the molecular function that catalyzes the cleavage of (S)-3-hydroxy-3-methylglutaryl-CoA into acetoacetate and acetyl-CoA, a committed step in ketogenesis and leucine catabolism.
• The canonical enzyme is HMGCL, a mitochondrial lyase; additional peroxisomal and cytosolic HMG-CoA lyase activities have been described, indicating metabolic compartmentalization.
• HMGCL deficiency causes 3-hydroxy-3-methylglutaric aciduria, a rare inherited metabolic disorder with episodes resembling Reye syndrome.
• HMGCL supports cancer progression: in glioblastoma it modulates histone acetylation and activates FOXM1/β-catenin signaling, and in pancreatic cancer its product β-hydroxybutyrate promotes tumor growth.
• Enzyme activity depends on catalytic residues and substrate binding elements, including Lys48 and the C-terminal region, and is sensitive to thiol/disulfide status.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of HMGCL function in metabolism, epigenetics, and oncology.
Description
Hydroxymethylglutaryl-CoA lyase activity (GO:0004419) is a molecular function that catalyzes the reaction (S)-3-hydroxy-3-methylglutaryl-CoA = acetoacetate + acetyl-CoA. This reaction is a terminal step in the ketogenic pathway and in leucine degradation, and it is essential for the production of ketone bodies that serve as alternative fuels during fasting or carbohydrate restriction. The enzyme responsible, HMGCL, is best characterized as a mitochondrial matrix protein, but peroxisomal and cytosolic HMG-CoA lyase activities have also been reported, suggesting broader metabolic roles. Because the reaction links lipid/ketone metabolism to acetyl-CoA pools and protein acetylation, its dysregulation has consequences for energy homeostasis, epigenetic regulation, and cell proliferation. Researchers study GO:0004419 to understand inherited metabolic disease, cancer metabolism, and the interplay between ketogenesis and chromatin modification. The availability of sensitive spectrophotometric assays for HMG-CoA lyase activity in human skin fibroblasts has facilitated diagnosis and functional characterization of patient variants. In addition, structure-function studies have identified residues and regions important for substrate binding and catalysis, providing a framework for interpreting disease-associated mutations.
hydroxymethylglutaryl-CoA lyase activity At A Glance
| GO ID | GO:0004419 |
|---|---|
| GO term | hydroxymethylglutaryl-CoA lyase activity |
| Ontology | molecular_function |
| Synonym | HMG-CoA lyase activity; 3-hydroxy-3-methylglutaryl-CoA lyase activity; hydroxymethylglutaryl coenzyme A lyase activity |
| Major function | Catalysis of (S)-3-hydroxy-3-methylglutaryl-CoA = acetoacetate + acetyl-CoA |
| Reaction direction | Lyase cleavage producing acetoacetate and acetyl-CoA |
| Primary enzyme | HMGCL (mitochondrial; additional peroxisomal and cytosolic activities reported) |
| Pathway context | Ketogenesis and leucine catabolism |
| Disease association | 3-hydroxy-3-methylglutaric aciduria; cancer metabolism |
What Is GO:0004419?
GO:0004419 describes the catalytic activity that converts (S)-3-hydroxy-3-methylglutaryl-CoA into acetoacetate and acetyl-CoA. In other words, it is a carbon-carbon bond-cleaving lyase reaction that releases acetoacetate, a ketone body precursor, and acetyl-CoA, a central metabolic intermediate. The activity is synonymous with HMG-CoA lyase activity and is measured biochemically by following the formation of acetoacetate or acetyl-CoA from the substrate.
Why Is hydroxymethylglutaryl-CoA lyase activity Important in Cell Biology?
GO:0004419 is important because it represents a metabolic node where ketone body production, acetyl-CoA supply, and protein acetylation intersect. The reaction product acetoacetate is a precursor to β-hydroxybutyrate, a signaling metabolite and energy substrate, while acetyl-CoA is a substrate for histone acetylation and other acetylation reactions. Consequently, changes in HMG-CoA lyase activity can influence gene expression programs, cell proliferation, and stress responses. Clinically, deficient activity causes 3-hydroxy-3-methylglutaric aciduria, an inherited disorder with potentially life-threatening metabolic crises. In cancer, HMGCL activity has been linked to glioblastoma progression through metabolic modulation of histone acetylation and FOXM1/β-catenin signaling, and to pancreatic cancer progression via β-hydroxybutyrate. Thus, understanding this activity is relevant to inborn errors of metabolism, oncology, and metabolic engineering.
• Defines a committed step in ketogenesis, supplying acetoacetate and acetyl-CoA during fasting or low-carbohydrate states.
• Participates in leucine catabolism, linking amino acid breakdown to ketone body production.
• Deficiency causes 3-hydroxy-3-methylglutaric aciduria, a rare metabolic disorder with Reye-like episodes.
• Supports cancer metabolism: HMGCL activity promotes glioblastoma and pancreatic cancer progression.
• Connects metabolism to epigenetics by influencing acetyl-CoA availability for histone acetylation.
• Provides a biochemical marker measurable in skin fibroblasts for diagnostic testing.
• Enzyme activity is sensitive to thiol/disulfide exchange, implicating redox regulation.
• Key residues such as Lys48 and the C-terminal region are important for substrate binding and activity.
• Engineered mutations can alter metabolic flux, as shown in MPA production studies.
• Offers a target for CRISPR-based functional genomics in metabolic and cancer research.
Molecular Mechanism of hydroxymethylglutaryl-CoA lyase activity
Substrate recognition and binding
In simple terms: The enzyme must grab the correct molecule, HMG-CoA, before it can cut it.
HMG-CoA lyase binds (S)-3-hydroxy-3-methylglutaryl-CoA, the substrate specified in GO:0004419. Structural and mutational studies have implicated the C-terminal end and Lys48 in substrate binding and enzyme activity, indicating that these elements contribute to proper substrate orientation and catalysis. The enzyme is specific for the (S)-stereoisomer of HMG-CoA, consistent with the definition of the activity.
Catalytic cleavage
In simple terms: The enzyme breaks HMG-CoA into two smaller molecules: acetoacetate and acetyl-CoA.
The lyase reaction cleaves the carbon-carbon bond of (S)-3-hydroxy-3-methylglutaryl-CoA to yield acetoacetate and acetyl-CoA. This is the defining catalytic event of GO:0004419. The reaction is reversible in principle, but under physiological conditions it contributes to ketogenesis and leucine catabolism by generating acetoacetate and acetyl-CoA.
Cofactors and redox sensitivity
In simple terms: The enzyme's activity can be switched on or off by the cell's redox state.
Avian HMG-CoA lyase activity is sensitive to thiol/disulfide exchange, and proximal reactive cysteines have been identified, suggesting that redox modifications can regulate the enzyme. This property may link HMG-CoA lyase activity to cellular oxidative stress and redox signaling.
Compartmentalization and multiple forms
In simple terms: The same chemical reaction can occur in different parts of the cell.
Beyond the classical mitochondrial enzyme, peroxisomal and cytosolic HMG-CoA lyase activities have been described, indicating that GO:0004419 can be carried out in multiple cellular compartments. This compartmentalization may allow distinct metabolic roles for the reaction products in different contexts.
Regulation by metabolic state
In simple terms: When the body needs ketones, this enzyme's activity becomes more important.
HMG-CoA lyase activity is part of the ketogenic pathway that is upregulated during fasting or carbohydrate restriction, when acetyl-CoA is diverted toward ketone body synthesis. In cancer cells, HMGCL activity can support proliferation by supplying acetyl-CoA for histone acetylation and by producing β-hydroxybutyrate, which can act as a signaling molecule.
Key Genes Involved in GO:0004419 hydroxymethylglutaryl-CoA lyase activity
The following genes and proteins are directly or indirectly associated with hydroxymethylglutaryl-CoA lyase activity (GO:0004419) and its metabolic context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HMGCL | Encodes the canonical mitochondrial HMG-CoA lyase that catalyzes GO:0004419 | Central to ketogenesis, leucine catabolism, and 3-hydroxy-3-methylglutaric aciduria |
| HMGCS1 | Cytosolic HMG-CoA synthase, produces HMG-CoA for cholesterol synthesis | Provides substrate for HMG-CoA lyase in cytosolic contexts |
| HMGCS2 | Mitochondrial HMG-CoA synthase, produces HMG-CoA for ketogenesis | Upstream of HMGCL in the ketogenic pathway |
| ACAT1 | Mitochondrial acetoacetyl-CoA thiolase, contributes to ketone body metabolism | Interacts with HMGCL pathway in leucine catabolism |
| FOXM1 | Transcription factor activated downstream of HMGCL-mediated metabolic changes | Linked to glioblastoma progression via β-catenin signaling |
| CTNNB1 | Encodes β-catenin, a transcriptional co-activator | Mediates HMGCL-dependent signaling in glioblastoma |
| SLC25A1 | Mitochondrial citrate carrier, supports acetyl-CoA metabolism | Indirectly affects substrate availability for HMGCL |
| BDH1 | Converts acetoacetate to β-hydroxybutyrate | Acts downstream of HMGCL product acetoacetate |
| OXCT1 | Ketone body utilization enzyme | Links HMGCL-derived ketones to energy metabolism |
| ACSS2 | Acetyl-CoA synthetase, contributes to acetyl-CoA pools | Modulates acetyl-CoA availability for acetylation |
| EP300 | Histone acetyltransferase using acetyl-CoA | Mediates epigenetic effects of HMGCL-derived acetyl-CoA |
| CREBBP | Histone acetyltransferase | Contributes to acetylation downstream of HMGCL |
| SIRT1 | NAD+-dependent deacetylase | Counterbalances acetylation influenced by HMGCL |
| PPARGC1A | Transcriptional coactivator regulating mitochondrial metabolism | May influence ketogenic gene expression including HMGCL |
| HNF4A | Transcription factor regulating metabolic genes | Potential regulator of HMGCL expression |
| SREBF1 | Lipogenic transcription factor | Opposes ketogenic program where HMGCL acts |
| MLYCD | Malonyl-CoA decarboxylase, regulates malonyl-CoA levels | Indirectly affects ketogenic flux |
| CPT1A | Carnitine palmitoyltransferase 1A, controls fatty acid oxidation | Supplies acetyl-CoA for ketogenesis upstream of HMGCL |
How Is hydroxymethylglutaryl-CoA lyase activity Regulated?
HMG-CoA lyase activity is regulated at multiple levels. Transcriptionally, the ketogenic program including HMGCL is induced by fasting and hormonal signals, while lipogenic transcription factors such as SREBF1 oppose it. Post-translationally, the enzyme is sensitive to thiol/disulfide exchange, and reactive cysteines can modulate activity in response to redox state. Metabolically, substrate supply from HMGCS2 and fatty acid oxidation controls flux through the reaction, and product removal by downstream enzymes such as BDH1 influences net activity. In cancer cells, oncogenic signaling can co-opt HMGCL activity to support histone acetylation and proliferation, linking metabolic regulation to epigenetic control.
hydroxymethylglutaryl-CoA lyase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HMGCL | 3-Hydroxy-3-methylglutaric aciduria | Patient-derived fibroblasts; HMGCL knockout cell lines |
| HMGCL | Glioblastoma progression via FOXM1/β-catenin | Glioblastoma cell lines with HMGCL knockout or overexpression |
| HMGCL | Pancreatic cancer progression via β-hydroxybutyrate | Pancreatic cancer organoids or xenografts with HMGCL modulation |
| HMGCL | Metabolic engineering of MPA production | Fungal or plant transformation with HMGCL insertion mutations |
| HMGCL | Redox regulation of enzyme activity | Cell-free assays with thiol/disulfide modifying agents |
3-Hydroxy-3-methylglutaric aciduria
Deficiency of HMG-CoA lyase activity causes 3-hydroxy-3-methylglutaric aciduria, an autosomal recessive inborn error of metabolism. Patients can present with metabolic acidosis, hypoglycemia, and episodes resembling Reye syndrome, which may be life-threatening. Diagnosis is supported by measuring HMG-CoA lyase activity in skin fibroblasts using a simple spectrophotometric method. The disorder highlights the critical role of GO:0004419 in energy homeostasis during catabolic stress.
Glioblastoma
In glioblastoma, HMGCL-mediated metabolic modulation of histone acetylation activates the FOXM1/β-catenin pathway, promoting tumor progression. This links GO:0004419 directly to epigenetic regulation and oncogenic signaling, suggesting that targeting HMGCL activity could disrupt a metabolic-epigenetic axis in brain tumors.
Pancreatic cancer
Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression, indicating that GO:0004419 supports tumor growth in this context. The enzyme may therefore represent a metabolic vulnerability in pancreatic cancer.
Metabolic engineering and bioproduction
Insertion mutations in HMG-CoA lyase can increase the production yield of mycophenolic acid (MPA) through Agrobacterium tumefaciens-mediated transformation, demonstrating that altering this activity can be exploited for metabolic engineering.
From hydroxymethylglutaryl-CoA lyase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of HMGCL affect ketogenesis and acetyl-CoA levels? | HMGCL knockout cell lines (e.g., HepG2, HEK293T) |
| Does a specific patient variant impair catalytic activity? | Point-mutation knock-in of HMGCL variant in isogenic cell lines |
| Can HMGCL activity be monitored in live cells? | Knock-in of fluorescent or affinity tags at the endogenous HMGCL locus |
| Does HMGCL overexpression drive proliferation? | Doxycycline-inducible HMGCL overexpression in cancer cell lines |
| Which metabolic pathways depend on HMGCL? | CRISPR knockout followed by metabolomics and RNA-seq |
| Can HMGCL mutations enhance metabolite production? | Insertion or point mutations in HMGCL in production strains |
How to Study the hydroxymethylglutaryl-CoA lyase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Spectrophotometric enzyme assay | HMG-CoA lyase catalytic activity | Diagnosis of 3-hydroxy-3-methylglutaric aciduria; variant validation |
| LC-MS metabolomics | Acetoacetate, β-hydroxybutyrate, acetyl-CoA levels | Assessing metabolic flux through HMGCL |
| RNA-seq | Transcriptional changes after HMGCL perturbation | Identifying downstream pathways |
| ChIP-seq | Histone acetylation marks | Linking HMGCL to epigenetic regulation |
| CRISPR knockout screening | Gene essentiality and metabolic dependencies | Cancer cell line fitness studies |
| Western blot | Protein expression of HMGCL and pathway members | Validating knockout or overexpression |
| Immunofluorescence | Subcellular localization of HMGCL | Distinguishing mitochondrial vs peroxisomal pools |
| Site-directed mutagenesis | Effect of specific residues on activity | Mapping catalytic and substrate-binding residues |
Enzymatic activity assays
HMG-CoA lyase activity can be measured spectrophotometrically in cell lysates or fibroblasts, following the formation of acetoacetate or acetyl-CoA. Such assays are essential for confirming that a variant or knockout affects GO:0004419 directly.
Metabolomics and flux analysis
Mass spectrometry-based metabolomics can quantify acetoacetate, β-hydroxybutyrate, and acetyl-CoA to assess flux through the HMGCL reaction. Stable isotope tracing can further define pathway contributions.
Transcriptomics and epigenomics
RNA-seq and ChIP-seq for histone acetylation can reveal downstream effects of HMGCL activity on gene expression and chromatin state, as shown in glioblastoma models.
CRISPR screening and functional genomics
Pooled CRISPR knockout screens can identify dependencies on HMGCL and related metabolic genes in cancer cell lines, linking GO:0004419 to fitness and drug response.
How CRISPR Can Be Used to Study GO:0004419 hydroxymethylglutaryl-CoA lyase activity
Knockout
CRISPR knockout of HMGCL eliminates GO:0004419 activity, enabling studies of ketogenesis, acetyl-CoA pools, and cancer cell proliferation. Knockout models can be validated by enzyme assays and metabolomics.
Point Mutation
Point mutations in HMGCL, such as those affecting Lys48 or the C-terminal region, can be introduced to dissect substrate binding and catalysis. These models help determine whether specific patient variants impair activity.
Knock-in
Knock-in of tags or reporter sequences at the endogenous HMGCL locus allows tracking of expression and localization without overexpression artifacts. This is useful for studying mitochondrial versus peroxisomal forms.
Overexpression
Overexpression of HMGCL can drive increased ketone body production and, in cancer models, promote proliferation and epigenetic changes. Inducible systems allow temporal control of GO:0004419 activity.
How EDITGENE Supports hydroxymethylglutaryl-CoA lyase activity Research
Researchers studying hydroxymethylglutaryl-CoA lyase activity-related genes often need to determine whether a candidate gene is causally involved in metabolic or oncogenic phenotypes. This requires precise, reproducible genetic models that isolate the function of HMGCL and its pathway partners.
Contact EDITGENE today to design your custom CRISPR model for hydroxymethylglutaryl-CoA lyase activity research.
Frequently Asked Questions About hydroxymethylglutaryl-CoA lyase activity
What is hydroxymethylglutaryl-CoA lyase activity?
It is the catalytic activity defined by GO:0004419 that converts (S)-3-hydroxy-3-methylglutaryl-CoA into acetoacetate and acetyl-CoA, a key step in ketogenesis and leucine catabolism.
What genes are involved in hydroxymethylglutaryl-CoA lyase activity?
The primary gene is HMGCL, which encodes the mitochondrial enzyme; additional peroxisomal and cytosolic activities have been reported.
What is the GO ID for hydroxymethylglutaryl-CoA lyase activity?
The GO ID is GO:0004419, under the molecular_function ontology.
What diseases are associated with HMG-CoA lyase deficiency?
HMG-CoA lyase deficiency causes 3-hydroxy-3-methylglutaric aciduria, which can present with Reye-like episodes and metabolic acidosis.
How is HMG-CoA lyase activity measured?
It can be measured spectrophotometrically in human skin fibroblasts or cell lysates by following acetoacetate or acetyl-CoA formation.
Is HMG-CoA lyase involved in cancer?
Yes, HMGCL activity supports glioblastoma progression via FOXM1/β-catenin signaling and pancreatic cancer progression via β-hydroxybutyrate.
What is the role of HMGCL in ketogenesis?
HMGCL catalyzes the final cleavage step that produces acetoacetate, a precursor to β-hydroxybutyrate, during ketogenesis.
Which residues are important for HMG-CoA lyase activity?
Lys48 and the C-terminal region have been implicated in substrate binding and enzyme activity.
Can HMG-CoA lyase activity be regulated by redox?
Yes, the enzyme is sensitive to thiol/disulfide exchange, and reactive cysteines can modulate its activity.
How can CRISPR be used to study HMG-CoA lyase activity?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of HMGCL function in metabolism and disease.
Conclusion
GO:0004419, hydroxymethylglutaryl-CoA lyase activity, is a central metabolic function that links ketogenesis, leucine catabolism, and acetyl-CoA-dependent processes such as histone acetylation. Its dysregulation causes a rare inherited metabolic disorder and contributes to cancer progression, making it a compelling target for both diagnostic and therapeutic research. Advances in CRISPR-based models and multi-omics profiling now allow precise interrogation of HMGCL and its pathway in physiologically relevant systems. Continued study of this activity will clarify how metabolic flux shapes cell fate and disease.
References
- 1. Sun Y et al.. 2024. Metabolic modulation of histone acetylation mediated by HMGCL activates the FOXM1/β-catenin pathway in glioblastoma.. Neuro Oncol 26(4):653-669 PMID: 38069906
- 2. Arnedo M et al.. 2019. More Than One HMG-CoA Lyase: The Classical Mitochondrial Enzyme Plus the Peroxisomal and the Cytosolic Ones.. Int J Mol Sci 20(24) PMID: 31817290
- 3. Wanders RJ et al.. 1988. 3-Hydroxy-3-methylglutaryl-CoA lyase in human skin fibroblasts: study of its properties and deficient activity in 3-hydroxy-3-methylglutaric aciduria patients using a simple spectrophotometric method.. Clin Chim Acta 171(1):95-101 PMID: 2450702
- 4. Hruz PW et al.. 1992. Avian 3-hydroxy-3-methylglutaryl-CoA lyase: sensitivity of enzyme activity to thiol/disulfide exchange and identification of proximal reactive cysteines.. Protein Sci 1(9):1144-53 PMID: 1304393
- 5. Robinson BH et al.. 1980. Hydroxymethylglutaryl CoA lyase deficiency: features resembling Reye syndrome.. Neurology 30(7 Pt 1):714-8 PMID: 6156427
- 6. Dong Y et al.. 2016. Insertion Mutation in HMG-CoA Lyase Increases the Production Yield of MPA through Agrobacterium tumefaciens-Mediated Transformation.. J Microbiol Biotechnol 26(11):1924-1932 PMID: 27558440
- 7. Gouirand V et al.. 2022. Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression.. EMBO J 41(9):e110466 PMID: 35307861
- 8. Carrasco P et al.. 2007. C-terminal end and aminoacid Lys48 in HMG-CoA lyase are involved in substrate binding and enzyme activity.. Mol Genet Metab 91(2):120-7 PMID: 17459752
